Intrathecal immunoactivation in patients with HIV-1 infection is reduced by zidovudine but not by didanosine

Scandinavian Journal of Infectious Diseases

Volumn 28, Issue 4, 1996, Pages 329-333

  Hagberg, Lars ^a,c   Norkrans, Gunnar ^a   Gisslén, Magnus ^a   Wachter, Helmut ^b   Fuchs, Dietmar ^b   Svennerholm, B O ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; DIDANOSINE; NEOPTERIN; ZIDOVUDINE;

ADULT; AGED; ARTICLE; CELL COUNT; CEREBROSPINAL FLUID CYTOLOGY; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONOCYTE;

EID: 0029793808     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549609037914     Document Type: Article

References (17)

1. Ho DD, Rota TR, Schooley RT, Kaplan JC, Allan JD, Groopman JE, Resnick L, Felsenstein D, Andrews CA, Hirsch MS. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 313: 1493-1497, 1985.
2. Chiodi F, Keys B, Albert J, Hagberg L, Lundeberg J, Uhlén M, Fenyö E-M, Norkrans G. HIV-1 is present in the cerebrospinal fluid of the majority of infected individuals. J Clin Microbiol 30: 1768-1771, 1992.
3. Sönnerborg A, Johansson B, Strannegård Ö. Detection of HIV-1 DNA and infectious virus in cerebrospinal fluid. AIDS Res Hum Retrovirus 7: 369-373, 1991.
4. Gisslén M, Chiodi F, Fuchs D, Norkrans G, Svennerholm B, Wachter H, Hagberg L. Markers of immune stimulation in the cerebrospinal fluid during HIV infection: A longitudinal study. Scand J Infect Dis 26: 523-533, 1994.
5. Portegies P, de Gans J, Lange JMA, Derix MMA, Speelman H, Bakker M, Danner SA, Goudsmit J. Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. Br Med J 299: 819-821, 1989.
6. Portegies P, Enting RH, de Jong MD. Aids dementia complex and didanosine. Lancet 344: 759, 1994.
7. 2-microglobulin levels in neurologically asymptomatic HIV-infected patients before and after initiation of zidovudine treatment. Infection 20: 313-315, 1992.
8. 2-microglobulin in patients with AIDS dementia complex: an expanded series including responses to zidovudine treatment. AIDS 6: 461-465, 1992.
9. Center for Disease Control (CDC). 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 41 (RR-17): 1-18, 1993.
10. Aurelius E, Forsgren M, Sköldenberg B, Strannegård Ö. Persistent intrathecal immunoactivation in patients with herpes simplex encephalitis. J Infect Dis 168: 1248-1252, 1993.
11. Hutterer, J. Amburster C, Wallner G, Fuchs D, Vetter N, Wachter H. Early changes of neopterin concentrations during treatment of human immunodeficiency virus infection with zidovudine. J Infect Dis 165: 783-784, 1992.
12. Min Liu J, Fahey JL, Aziz N, Cumberland WG, Skowron G, Merigan T. Zidovudine and dideoxycytidine differ in their effects on human immunodeficiency virus-induced pathologic activation of the immune system. J Infect Dis 170: 1165-1171, 1994.
13. 2-microglobulin levels in mildly symptomatic, HIV type 1 seropositive individuals. J Aquir Imm Def Syndr 5: 215-221, 1992.
14. Vago L, Castagna A, Lazzarin A, Trabattoni G, Cinque P, Costanzi G. Reduced frequency of HIV-induced brain lesions in AIDS patients treated with zidovudine. J Aquir Imm Def Syndr 6: 42-45, 1993.
15. Gray F, Bélec L, Keohane C, De Truchis P, Clair B, Durigon M, Sobel A, Gherardi R. Zidovudine therapy and HIV encephalitis: a 10-year neuropathological survey. AIDS 8: 489-493, 1994.
16. Mahlen J, Dunlop O, Liestol K, Dobloug HJ, Goplen AK, Torvik A. Changing incidence of HIV-induced brain lesions in Oslo, 1983-1994: effects of zidovudine treatment. AIDS 9: 1171-1175, 1995.
17. Burger DM, Kraaijeveld CL, Meenhorst PL, Mulder JW, Koks CHW, Bult A, Beijnen JH. Penetration of zidovudine into the cerebrospinal fluid of patients infected with HIV. AIDS 7: 1581-1587, 1993.